Erik Harris insider trades

Open-market stock purchases and sales by Erik Harris, EVP & Chief Commercial Officer at Ultragenyx Pharmaceutical Inc, from SEC Form 4 filings since Jun 19, 2019.

Recent trades

DateStockTradeValue
Apr 16, 2026RARE Ultragenyx Pharmaceutical IncBought (not open market)—
Apr 16, 2026RARE Ultragenyx Pharmaceutical IncBought (not open market)—
Mar 2, 2026RARE Ultragenyx Pharmaceutical IncSold$240K
Mar 1, 2026RARE Ultragenyx Pharmaceutical IncBought (not open market)—
Nov 19, 2025RZLT Rezolute, IncBought (not open market)—
Nov 19, 2025RZLT Rezolute, IncBought (not open market)—

Companies traded

  • RARE Ultragenyx Pharmaceutical Inc: 19 sales, last Apr 16, 2026
  • RZLT Rezolute, Inc: other filings, last Nov 19, 2025
  • INZY Inozyme Pharma, Inc: other filings, last Oct 3, 2024
  • DNLI Denali Therapeutics Inc: other filings, last May 31, 2024

Get free alerts when Erik Harris files a new trade →